Notices. Notice announcing a two-day public workshop and requesting public comment and participation
5,034 words·~23 min read·
/register/2007/02/26/07-831A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6715-01-M FEDERAL TRADE COMMISSION Public Workshop; Proof Positive: New Directions for ID Authentication AGENCY: Federal Trade Commission (FTC). ACTION: Notice announcing a two-day public workshop and requesting public comment and participation. SUMMARY: The FTC and other participating agencies are planning to host a two-day public workshop to explore the role of authentication processes in preventing identity theft. The workshop will provide a forum for discussion among public sector, private sector, and consumer representatives about better ways to authenticate the identities of individuals.
DATES: Workshop, Proof Positive: New Directions for ID Authentication, will be held on April 23, 2007 from 8:30 a.m. to 5 p.m. and April 24, 2007, from 8:30 a.m. to 12:30 p.m., in the Federal Trade Commission's Satellite Building Conference Center located at 601 New Jersey Avenue, NW., Washington, DC. The events are open to the public and attendance is free of charge. There will be no pre-registration. *Participants:* As discussed below, written requests to participate as a panelist in the workshop must be filed on or before March 9, 2007.
Persons filing requests to participate as a panelist will be notified on or before March 23, 2007, if they have been selected to participate. *Comments:* Whether or not selected to participate, persons may submit written comments on the issues and topics set out below. Such comments must be filed on or before March 23, 2007. ADDRESSES: Interested parties are invited to submit requests to participate and comments in accordance with the following instructions: Requests To Participate as Panelist in Workshop:
Parties seeking to participate as panelists in the workshop must notify the FTC in writing of their interest in participating on or before March 9, 2007. Requests to participate as a panelist should be captioned “ID Workshop—Request to Participate, P075402” and may be submitted by any of the following methods. However, if the request contains any material for which confidential treatment is requested, it must be filed in paper form, and the first page of the document must be clearly labeled “Confidential.” 1 1 Commission Rule 4.2(d), 16 CFR 4.2(d).
The comment must be accompanied by an explicit request for confidential treatment, including the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. The request will be granted or denied by the Commission's General Counsel, consistent with applicable law and the public interest. *See* Commission Rule 4.9(c), 16 CFR 4.9(c). • *E-mail:* Requests to participate can be submitted electronically to: *idmworkshop@ftc.gov.* • *Mail or Hand Delivery:* A request to participate filed in paper form should include “ID Workshop, P075402,” both in the text and on the envelope and should be mailed or delivered to the following address:
Federal Trade Commission/Office of the Secretary, Room H-135 (Annex N), 600 Pennsylvania Avenue, NW., Washington, DC 20580. Because paper mail in the Washington area and at the Commission is subject to delay, please consider submitting your request by e-mail, as prescribed above. The FTC is requesting that any request filed in paper form be sent by courier or overnight service, if possible. Parties should include in their requests a statement setting forth their expertise in or knowledge of the issues on which the workshop will focus and their contact information, including a telephone number, facsimile number, and e-mail address (if available), to enable the FTC to notify them if they are selected.
FTC staff will select a limited number of panelists to participate in the workshop, using the following criteria. 1. The party has expertise in or knowledge of the issues that are the focus of the workshop; 2. The party's participation would promote a balance of interests being represented at the workshop; and 3. The party has been designated by one or more interested parties (who timely file requests to participate) as a party who shares group interests with the designator(s).
The FTC will notify panelists on or before March 23, 2007, as to whether they have been selected. The number of parties selected will not be so large as to inhibit effective discussion among them. For those not serving as panelists, there also will be time during the workshop to ask questions. Comments The FTC requests that interested parties submit written comments on the issues raised below. Studies, surveys, research, and empirical data are especially useful. Comments should be captioned “ID Workshop—Comment, P075402” and must be filed on or before March 23, 2007.
If the comment contains any material for which confidential treatment is requested, it must be filed in paper form, and the first page of the document must be clearly labeled “Confidential.” 2 Otherwise, comments may be submitted by any of the following methods. 2 Commission Rule 4.2(d), 16 CFR 4.2(d). The comment must be accompanied by an explicit request for confidential treatment, including the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record.
The request will be granted or denied by the Commission's General Counsel, consistent with applicable law and the public interest. *See* Commission Rule 4.9(c), 16 CFR 4.9(c). • *Electronic Filing:* Comments filed in electronic form should be submitted by clicking on the following Web link: *https://secure.commentworks.com/ftc-idmworkshop* and following the instructions on the Web-based form. To ensure that the Commission considers an electronic comment, you must file it on the Web-based form at *https://secure.commentworks.com/ftc-idmworkshop.* • *Mail or Hand Delivery:* A comment filed in paper form should include “ID Workshop, P075402,” both in the text and on the envelope and should be mailed or delivered to the following address:
Federal Trade Commission/Office of the Secretary, Room H-135 (Annex N), 600 Pennsylvania Avenue, NW., Washington, DC 20580. Because paper mail in the Washington area and at the Commission is subject to delay, please consider submitting your comments in electronic form, as prescribed above. The FTC is requesting that any comment filed in paper form be sent by courier or overnight service, if possible. The FTC Act and other laws the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate.
All timely and responsive public comments, whether filed in paper or electronic form, will be considered by the Commission and will be available to the public on the FTC Web site, to the extent practicable, at *http://www.ftc.gov/os/publiccomments.htm.* As a matter of discretion, the FTC makes every effort to remove home contact information for individuals from the public comments it receives before placing those comments on the FTC Web site. More information, including routine uses permitted by the Privacy Act, may be found in the FTC's privacy policy, at *http://www.ftc.gov/ftc/privacy.htm.* FOR FURTHER INFORMATION CONTACT:
Stacey Brandenburg, Joanna Crane, or Naomi Lefkovitz at (202)-326-2252. SUPPLEMENTARY INFORMATION: Background and Proposed Agenda Identity theft takes many forms and is committed for various purposes, including financial gain, avoidance of criminal penalties, and facilitating criminal activity (e.g., opening new credit accounts or draining bank accounts, evading criminal arrest warrants, and facilitating terrorist activities). But in its most basic form, it is a crime of deception relying on the unauthorized use of identifying information or credentials of another individual.
At present, many transactions that depend on correct identification are conducted either remotely, or if in person, between individuals who are strangers. Because such transactions necessarily rely on an individual's use of identifying information or credentials in order to prove his or her identity, there is a potential risk of identity theft. Thus, the ability to determine when an individual is not who he or she purports to be is an important key to preventing identity theft.
The Identity Theft Task Force (“Task Force”) was established by Executive Order of the President on May 10, 2006. The Order directed the Task Force to deliver a strategic plan to the President on the Federal Government's response to identity theft. The Task Force, which is chaired by the Attorney General and co-chaired by the Chairman of the FTC, delivered an interim set of recommendations on September 19, 2006 that included the recommendation to hold a workshop focused on promoting improved means of authenticating the identities of individuals. 3 3 President's Identity Theft Task Force Summary of Interim Recommendations (2006), available at *http://www.ftc.gov/opa/2006/09/idtheft.htm.* To implement the Task Force's recommendation and to begin greater study of this area, the FTC and other Task Force agencies 4 will hold a workshop to explore the means by which identity theft can be prevented through better authentication of individuals. 5 The workshop will facilitate a discussion among public sector, private sector, and consumer representatives and will focus on technological and policy requirements for developing better authentication processes, including the incorporation of privacy standards and consideration of consumer usability. 4 For a list of the agencies comprising the Task Force, see Executive Order:
Strengthening Federal Efforts to Protect Against Identity Theft (2006), available at *http://www.whitehouse.gov/news/releases/2006/05/20060510-3.html.* 5 The term “authentication” generally means the process of ensuring that an individual is who she or he claims to be. However, this process is more easily understood as comprising two distinct steps. The first step is the identification of an individual at the onset of the relationship between the individual and the verifying entity (e.g., an individual's identity will be verified when he or she applies for a passport or opens a financial account).
The second step is the reaffirmation that the individual is the same individual whose identity was initially verified (e.g., the individual's passport is checked when he or she travels in or out of the country or the individual provides a password or other credentials to the financial institution when accessing an existing account). Although different terms can be applied to these steps, the first step is often labeled verification and the second step, particularly with respect to online environments, is often labeled authentication.
For greater clarity, these distinctions are used in the invitation for comment section set forth herein. To help in planning for the workshop, the FTC invites comments on ways to improve authentication processes in order to reduce the incidence of identity theft, including but not limited to, comments on the issues and topics set out below: 1. Establishing Identity—Understanding Verification Processes • In what ways can identities be established? How can individuals prove their identities when establishing them in the first instance? • Please comment on the strengths and weaknesses of relying on traditional identification documentation or credentials such as birth certificates, Social Security cards, driver's licenses, and passports. • Please comment on the strengths and weaknesses of new or emerging tools for establishing individuals' identities.
Examples may include consumer information databases, which can be used to confirm whether a name and other personal information (e.g., Social Security number) belong together, and fraud detection software, which can be used to identify anomalous patterns or behaviors that may signal use of a false identity. • What roles should the public sector or the private sector have in establishing identification credentials? Within the public sector, what roles should different levels of government (i.e., federal, state, local) have in establishing identification credentials? 2.
Confirming the Established Identity—Current or Emerging Use of Authentication Technologies or Methods • What are some current or emerging authentication technologies or methods (e.g., biometrics, public key infrastructure, knowledge-based authentication) for confirming established identities? Describe the contexts in which they may be used and their strengths and weaknesses. • Please comment on the concept of multifactor authentication and how it is being or should be applied. • To what extent are consumer information databases being used to authenticate individuals? One example of such use is to support knowledge-based authentication tools, which generate questions the answers to which only the consumer would know. • To what extent do current or emerging authentication technologies or methods incorporate or rely on readily available identification information, such as Social Security numbers? How might such reliance affect the risk of identity theft? • To what extent do these technologies or methods meet consumer needs, such as ease of use? To what extent do these technologies or methods raise privacy concerns, including concerns about the tracking and profiling of an individual's movements or transactions by the public or private sector? 3.
Comparing Verification and Authentication Systems • What are some of the different models for verification and authentication systems? Please comment on their strengths and weaknesses. For example, what are the relative merits of a centralized identification system where a single or a limited number of organizations identify all individuals and issue credentials that other entities can rely upon versus a decentralized identification system where each organization develops its own procedures and separately verifies and authenticates the individuals with which it is involved? • In considering the relative merits of different systems, please comment on: ○ Consumer acceptance and to what degree consumer education may facilitate such acceptance; and ○ Any privacy concerns including issues raised with respect to data collection, use, and storage. • In addition to reducing identity theft, how might better systems or processes for proving claims of identity generate other consumer benefits (e.g., providing access to various commercial or government services)? • How are other countries addressing verification and authentication issues, particularly as the issues relate to identity theft? What lessons can be learned? 4.
Upcoming Challenges in Authentication • As technologies converge to allow consumers to conduct financial or other sensitive transactions in new ways, how can appropriate authentication processes or technologies be incorporated to ensure that consumers receive the intended benefits of these advances without exposing them to new vulnerabilities? By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E7-3238 Filed 2-23-07; 8:45 am] BILLING CODE 6750-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary [Document Identifier:
OS-0990-0000] [60-day notice] Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Office of the Secretary, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects:
(1)The necessity and utility of the proposed information collection for the proper performance of the agency's functions;
(2)the accuracy of the estimated burden;
(3)ways to enhance the quality, utility, and clarity of the information to be collected; and
(4)the use of automated collection techniques or other forms of information technology to minimize the information collection burden. *Type of Information Collection Request:* New collection. *Title of Information Collection:* Understanding Barriers and Successful Strategies for Faith-Based Organizations in Accessing Grants. *Form/OMB No.:* 0990- *Use:* The “Understanding Barriers and Successful Strategies for Faith-Based Organizations in Accessing Grants” study aims to complement internal Health and Human Services
(HHS)efforts to provide equal access to federal discretionary grants for faith-based organizations by collecting information directly from such organizations on their experiences applying for federal grants. *Frequency:* Single time. *Affected Public:* Not-for-profit institutions. *Annual Number of Respondents:* 290. *Total Annual Responses:* 290. *Average Burden per Response:* 35.3 minutes. *Total Annual Hours:* 170. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to *Sherette.funncoleman@hhs.gov* , or call the Reports Clearance Office on
(202)690-6162. Written comments and recommendations for the proposed information collections must be received with 60 days, and directed to the OS Paperwork Clearance Officer at the following address: Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Resources and Technology, Office of Resources Management, Attention: Sherrette Funn-Coleman (0990-NEW), Room 537-H, 200 Independence Avenue, SW., Washington, DC 20201. Dated: February 15, 2007. Alice Bettencourt, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. E7-3175 Filed 2-23-07; 8:45 am] BILLING CODE 4154-07-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary [Document Identifier: OS-0990-0243] [60-day notice] Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Office of the Secretary, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects:
(1)The necessity and utility of the proposed information collection for the proper performance of the agency's functions;
(2)the accuracy of the estimated burden;
(3)ways to enhance the quality, utility, and clarity of the information to be collected; and
(4)the use of automated collection techniques or other forms of information technology to minimize the information collection burden. *Type of Information Collection Request:* Extension. *Title of Information Collection:* OCR Pre-grant Data Request Form. *Form/OMB No.:* 0990-0243. *Use:* The form is designed to collect data from health care providers who have requested certification to participate in the Medicare program. This civil rights compliance determination is an essential component of HHS' decision to grant or deny certification and must be made prior to the Department's final notification of its decision to the provider. *Frequency:* Recordkeeping single time. *Affected Public:* Business or other for-profit. *Annual Number of Respondents:* 3,500. *Total Annual Responses:* 3,500. *Average Burden per Response:* 15 hours. *Total Annual Hours:* 52,500. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to *Sherette.funncoleman@hhs.gov* , or call the Reports Clearance Office on
(202)690-6162. Written comments and recommendations for the proposed information collections must be received with 60-days, and directed to the OS Paperwork Clearance Officer at the following address: Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Resources and Technology, Office of Resources Management, Attention: Sherrette Funn-Coleman (0990-0243), Room 537-H, 200 Independence Avenue, SW., Washington DC 20201. Dated: February 15, 2007. Alice Bettencourt, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. E7-3177 Filed 2-23-07; 8:45 am] BILLING CODE 4153-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Announcement of the Availability of the Hydroxyurea Expert Panel Report; Request for Public Comment AGENCY: National Institute of Environmental Health Sciences; National Institutes of Health, HHS. ACTION: Request for comment. SUMMARY: CERHR announces availability of the hydroxyurea expert panel report by March 5, 2007 on the CERHR Web site ( *http://cerhr.niehs.nih.gov* ) or in print from CERHR (see “ ADDRESSES ” below). This expert panel report is an evaluation of the reproductive and developmental toxicity of hydroxyurea conducted by a 13-member expert panel composed of scientists from the Federal Government, universities, and private organizations. CERHR invites the submission of public comments on this expert panel report. DATES: The final hydroxyurea expert panel report will be available by March 5, 2007, and written public comments on this report should be received by April 18, 2007. ADDRESSES: Public comments and any other correspondence should be sent to Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box 12233, MD EC-32, Research Triangle Park, NC 27709 (mail),
(919)316-4511 (fax), or *shelby@niehs.nih.gov* (e-mail). Courier address: CERHR, 79 T.W. Alexander Drive, Building 4401, Room 103, Research Triangle Park, NC 27709. SUPPLEMENTARY INFORMATION: Background Hydroxyurea is used in the treatment of cancer, sickle cell disease, and thalassemia. It is the only treatment for sickle cell disease used in children aside from blood transfusion. Hydroxyurea may be used in the treatment of children and adults with sickle cell disease for an extended period of time or for repeated cycles of therapy. Treatment with hydroxyurea may be associated with cytotoxic and myelosuppressive effects and hydroxyurea is mutagenic. Hydroxyurea is FDA-approved for reducing the frequency of painful crises and the need for blood transfusions in adults with sickle cell anemia who experience recurrent moderate to severe crises. CERHR selected hydroxyurea for expert panel evaluation because of
(1)increasing use in the treatment of sickle cell disease in children and adults,
(2)knowledge that it inhibits DNA synthesis and is cytotoxic, and
(3)published evidence of reproductive and developmental toxicity in rodents. The CERHR convened an expert panel on January 24-26, 2007, to review and revise the draft expert panel report and reach conclusions regarding whether exposure to hydroxyurea is a hazard to human development or reproduction. The expert panel also identified data gaps and research needs. Prior to the meeting, CERHR solicited public comment on the draft expert panel report ( **Federal Register** Vol. 71, No. 199 pp. 60746-60748). Following receipt of public comments on the hydroxyurea expert panel report, CERHR staff will prepare the NTP-CERHR monograph. NTP-CERHR monographs are divided into four major sections:
(1)The NTP Brief which provides the NTP's interpretation of the potential for the chemical to cause adverse reproductive and/or developmental effects in exposed humans,
(2)a roster of expert panel members,
(3)the final expert panel report, and
(4)public comments received on that report. The NTP Brief is based on the expert panel report, public comments on that report, public and peer review comments on the draft NTP Brief, and any new information that became available after the expert panel meeting. Request for Comments CERHR invites written public comments on the hydroxyurea expert panel report. Written comments should be sent to Dr. Michael Shelby at the address provided above. Persons submitting written comments are asked to include their name and contact information (affiliation, mailing address, telephone and facsimile numbers, e-mail, and sponsoring organization, if any). All comments received will be posted on the CERHR website and will be included in the NTP-CERHR monograph on hydroxyurea. The NTP will consider all public comments during preparation of the NTP Brief. Background Information on CERHR The NTP established CERHR in June 1998 [ **Federal Register** , December 14, 1998 (Vol. 63, No. 239, pp. 68782)]. CERHR is a publicly accessible resource for information about adverse reproductive and/or developmental health effects associated with exposure to environmental and/or occupational exposures. Expert panels conduct scientific evaluations of agents selected by CERHR in public forums. CERHR invites the nomination of agents for review or scientists for its expert registry. Information about CERHR and the nomination process can be obtained from its Web site ( *http://cerhr.niehs.nih.gov* ) or by contacting Dr. Shelby (see ADDRESSES above). CERHR selects chemicals for evaluation based upon several factors including production volume, potential for human exposure from use and occurrence in the environment, extent of public concern, and extent of data from reproductive and developmental toxicity studies. CERHR follows a formal, multi-step process for review and evaluation of selected chemicals. The formal evaluation process was published in the **Federal Register** notice July 16, 2001 (Vol. 66, No. 136, pp 37047-37048) and is available on the CERHR Web site under “About CERHR” or in printed copy from CERHR. Dated: February 12, 2007. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E7-3151 Filed 2-23-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day-07-0274] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention
(CDC)will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-5960 and send comments to Joan Karr, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to *omb@cdc.gov.* *Comments are invited on:*
(a)Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
(b)the accuracy of the agency's estimate of the burden of the proposed collection of information;
(c)ways to enhance the quality, utility, and clarity of the information to be collected; and
(d)ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project CDC Model Performance Evaluation Program
(MPEP)(0920-0274)—Revision—National Center for Preparedness, Detection, and Control of Infectious Diseases (proposed) (NCPDCID), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is requesting OMB approval of a revision to its data collection, the CDC Model Performance Evaluation Program (MPEP). CDC originally implemented MPEP in 1986 to evaluate the performance of laboratories conducting testing to detect human immunodeficiency virus type 1 (HIV-1) antibody (Ab). CDC is requesting a 3-year approval for this data collection. In this program, respondents receive 2 shipments of specimens per year. Respondents test the specimens in their laboratory/testing site and report their results either using a report booklet or on-line. CDC provides the respondent with a report containing the analysis of the laboratory test results reported to CDC. Participation in this program is voluntary and provides the respondents an opportunity to
(1)assure accurate tests are being provided by the laboratory/testing site through external quality assessment;
(2)improve testing quality through self-evaluation in a nonregulatory environment;
(3)test well characterized samples from a source outside the test kit manufacturer;
(4)discover potential testing problems so that procedures can be adjusted to eliminate them;
(5)compare of testing results with others at a national and international level; and
(6)consult with CDC staff to discuss testing issues. In this request, CDC proposes to make the following revisions to the currently approved data collection: • Addition of a Name and Address change form to report changes for the MPEP manager and coordinator at the respondent laboratory; • Inclusion of additional test kit manufacturers approved by the FDA since previous OMB approval; and • Elimination of reporting HIV-1 RNA Viral Load and CD4+ T-cell determinations. All respondents are MPEP affiliated laboratories. There is no cost to respondents other than their time. Estimate of Annualized Burden Hours Respondents (type of form) Number of respondents Frequency of response Average time per response Annual burden (in hours) New Enrollees 100 1 3/60 5 Laboratory Change Form 20 1 3/60 1 Laboratory Test Result Form 754 2 10/60 251 Total 257 Dated: February 20, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7-3167 Filed 2-23-07; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Research Member Conflict Review, Program Announcement Number
(PA)04-038 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention
(CDC)announces the following Meeting of the aforementioned committee: *Time and Date:* 1 p.m.-4 p.m., March 14, 2007 (Closed). *Place:* National Institute for Occupational Safety and Health, 626 Cochrans Mill Road, Pittsburgh, PA 15236. *Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. *Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of research grant applications in response to PA 04-038, “Occupational Safety and Health Research Member Conflict Review.” *Contact Person for More Information:* George Bockosh, Designated Federal Officer, National Institute for Occupational Safety and Health, 626 Cochrans Mill Road, Pittsburgh, PA 30333, telephone 412.386.6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7-3184 Filed 2-23-07; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Eye Institute Special Emphasis Panel; NEI Mentored Training Grant Applications (K series). *Date:* February 26, 2007. *Time:* 10 a.m. to 11 a.m. *Agenda:* To review and evaluate grant applications. *Place:* National Eye Institute, 5635 Fishers Lane, Suite 1300, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892-9300.
(301)451-2020, *aes@nei.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* National Eye Institute Special Emphasis Panel; NEI Epidemiology, Genetics and Data Analysis Grant Applications. *Date:* March 22, 2007. *Time:* 8:30 a.m. to 3:30 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. *Contact Person:* Houmam H. Araj, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, NIH, 5635 Fishers Lane, Suite 1300, Bethesda, MD 20892-9602, 301-451-2020, *haraj@mail.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision research, National Institutes of Health, HHS. Dated: February 15, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07-831 Filed 2-23-07; 8:45 am]
Connectionstraces to 2
1 reference not yet in our index
- Pub. L. 92-463
Citation graph
cites case law
Notices
Notice announcing a two-day public workshop and requesting public comment and participation
Pub. L.Pub. L. 92-463
Cites 3Cited by 0 across 0 sources